Research programme: undecaprenyl diphosphate synthase inhibitors - Merck
Alternative Names: Undecaprenyl diphosphate synthase inhibitors research programme - Merck; UppS inhibitors research programme - MerckLatest Information Update: 08 Feb 2017
At a glance
- Originator Cubist Pharmaceuticals
- Class
- Mechanism of Action Enzyme inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Anthrax
Most Recent Events
- 20 Sep 2004 No development reported - Preclinical for Anthrax in USA (unspecified route)
- 01 Aug 2002 Preclinical trials in Anthrax in USA (unspecified route)